Phenylephrine HCL Injection Recalled for Lack of Sterility Assurance
SterRx is recalling approximately 18,948 bags of Phenylephrine HCL in 0.9% Sodium Chloride injection nationwide due to lack of assurance of sterility. The product is distributed across the U.S.A.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable drug with a critical manufacturing defect (lack of sterility assurance). Injectable products lacking sterility assurance pose a direct risk of serious infection and contamination, meeting the threshold for Severe (4) per the rubric criterion for Class II recalls with significant risk of harm.
Plain-English summary
SterRx, LLC is recalling Phenylephrine HCL in 0.9% Sodium Chloride, 20 mg per 250 mL (80 mcg per mL), an intravenous injection medication. Approximately 18,948 bags have been distributed nationwide.
The recall is being issued because there is a lack of assurance of sterility for this product. Phenylephrine HCL is a prescription medication used as a vasopressor agent, and sterility is critical for injectable pharmaceutical products to prevent serious infections and contamination.
Affected lot codes include S21086/BQW (14-Dec-21), S21149/BTH (23-Jan-22), S21159/BTQ (30-Jan-22), S21265/BXI (3-Apr-22), S21305/BYU (24-Apr-22), and S21311/BZA (26-Apr-22). The product is identified by NDC 70324-701-01.
Patients and healthcare providers who have this product should stop using it and contact their pharmacy or healthcare provider. Healthcare facilities should quarantine any remaining stock and report any adverse events to the FDA MedWatch program.
The recalled product
- Product
- PHENYLepherine HCL in 0.9% Sodium Chloride, 20 mg per 250 mL (80 mcg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-701-01.
- Manufacturer
- SterRx, LLC
- Category
- Drug — Injectable / Vasopressor
- Affected units
- 18,948
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by SterRx, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · SterRx, LLC
See all →- HighNorepinephrine injectable recalled due to sterility assurance concerns
FDA (Drugs) · 2023-07-26
- HighNorepinephrine injectable recalled due to lack of sterility assurance
FDA (Drugs) · 2023-07-26
- HighNorepinephrine Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-07-26
- HighNorepinephrine injectable medication recalled nationwide for sterility assurance
FDA (Drugs) · 2023-07-26
- HighSodium Bicarbonate Injectable Solution Recalled for Sterility Assurance Issues
FDA (Drugs) · 2023-07-26
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24